The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 357:509-513 August 2, 2007 Number 5
NextNext

A Decline in Breast-Cancer Incidence

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Ravdin, P. M.
-PubMed Citation
To the Editor: In their Special Report on the decrease in the incidence of breast cancer in the United States in 2003, Ravdin et al. (April 19 issue)1 state that a 2002 report by the Women's Health Initiative (WHI)2 noted a significant increase in the risk of breast cancer associated with the use of estrogen–progestin combination therapy by postmenopausal women. However, the increased risk of breast cancer in the WHI study did not reach statistical significance. The increased risk of breast cancer in the follow-up report3 barely achieved statistical significance, and no increased risk was found among WHI study subjects . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.